Using AI to Improve Reimbursement and Decrease Claim Denials
Though payers’ adoption of AI has made reimbursement more challenging for labs, providers can also use AI to address these issues
Reimbursement-lca
Subscribe today for access to
Articles and Reports
Private Payer Reimbursement for Genetic Testing Hinges on Clinical Utility
Two revenue cycle management experts offer tips for clinical labs to improve coverage decisions for genetic tests
What Labs Need to Know About MolDX®
How the MolDX® program works, what it covers, and how it can support better test access, use, and reimbursement in the clinical lab
The 6 Changes to the 2022 Physician Fee Schedule Most Likely to Affect Your Lab
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
New Rules for CDLTs that Aren’t ADLTs Take Effect Jan. 1
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Labs and Private Payors Clash Over Reimbursement of COVID-19 Testing
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
OIG Medicare Lab Spending Report May Warn of Greater Scrutiny of Genetic and Automated Chemistry Tests
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
AMA Creates New CPT Code 87426 for COVID-19 Antigen Testing
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
CMS Issues Reminders for Billing COVID-19 Specimen Collection & Symptom/Exposure Assessment
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Scorecard: SVT False Billing Settlements Near the $3 Million Mark
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Labs In Court
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Medicare Reimbursement: MIPS Bonuses Are Easy to Earn, IF You Can Get into the Program
From - Lab Compliance Advisor
On July 11, CMS announced the results of 2018, Year 2 under the Merit-based Incentive Payment System…
Billing & Coding: Myriad Genetics Pays $9.1 Million to Settle Claims of Falsely Billing Medicare for Hereditary Cancer Tests
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here